# EDGAR Filing Document

**Accession Number:** 0001783044
**File Stem:** 0002071876-25-000050
**Filing Date:** 2025-9
**Character Count:** 8449
**Document Hash:** 841029a20c884a2d49b178d3530f1f65
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0002071876-25-000050.hdr.sgml**: 20250923

**ACCESSION NUMBER**: 0002071876-25-000050

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13G

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20250923

**DATE AS OF CHANGE**: 20250923

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** PRECIGEN, INC.
- **CENTRAL INDEX KEY:** 0001356090
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** VA
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13G
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-88073
- **FILM NUMBER:** 251333685

**BUSINESS ADDRESS:**
- **STREET 1:** 20374 SENECA MEADOWS PARKWAY
- **CITY:** GERMANTOWN
- **STATE:** MD
- **ZIP:** 20876
- **BUSINESS PHONE:** 301-556-9900

**MAIL ADDRESS:**
- **STREET 1:** 20374 SENECA MEADOWS PARKWAY
- **CITY:** GERMANTOWN
- **STATE:** MD
- **ZIP:** 20876

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** INTREXON CORP
- **DATE OF NAME CHANGE:** 20060313
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Miller William H III
- **CENTRAL INDEX KEY:** 0001783044

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13G

**MAIL ADDRESS:**
- **STREET 1:** C/O APG LLC
- **STREET 2:** ONE SOUTH STREET, SUITE 2550
- **CITY:** BALTIMORE
- **STATE:** MD
- **ZIP:** 21202

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13G

### Under the Securities Exchange Act of 1934

**Issuer:** PRECIGEN, INC.

**Title of Class of Securities:** Common Stock

**CUSIP Number:** 74017N105

**Date of Event Which Requires Filing of this Statement:** 06/26/2025

**Check the appropriate box to designate the rule pursuant to which this Schedule is filed:**

- [ ] Rule 13d-1(b)

- [x] Rule 13d-1(c)

- [ ] Rule 13d-1(d)

---

| 1. | Names of Reporting Persons<br>William H. Miller III Living Trust dated April 17, 2017 | Names of Reporting Persons<br>William H. Miller III Living Trust dated April 17, 2017 |
|:---|:---|:---|:---|
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [ ] | Check the Appropriate Box if a Member of a Group (See Instructions)<br>(a) [ ] (b) [ ] |
| 3. | SEC Use Only | SEC Use Only |
| 4. | Citizenship or Place of Organization<br>FL | Citizenship or Place of Organization<br>FL |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 5. | Sole Voting Power<br>34051925.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 6. | Shared Voting Power<br>0.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 7. | Sole Dispositive Power<br>34051925.00 |
| Number of<br>Shares<br>Beneficially<br>Owned by<br>Each<br>Reporting<br>Person<br>With | 8. | Shared Dispositive Power<br>0.00 |
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person<br>34051925.00 | Aggregate Amount Beneficially Owned by Each Reporting Person<br>34051925.00 |
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] |
| 11. | Percent of Class Represented by Amount in Row (9)<br>9.2% | Percent of Class Represented by Amount in Row (9)<br>9.2% |
| 12. | Type of Reporting Person (See Instructions)<br>OO | Type of Reporting Person (See Instructions)<br>OO |

**Comment for Type of Reporting Person:** Note (A) for Lines 5, 7, and 9 - Includes 16,666,667 shares of Common Stock that the Reporting Person could acquire within 60 days upon the exercise of warrants.
Note (B) for Line 11 - Based on 298,455,084 shares of Common Stock outstanding as of September 11, 2025, as reported to the Reporting Person by the Issuer's Chief Financial Officer, plus (i) an additional 54,937,411 shares of Common Stock delivered to certain holders of the Issuer's preferred stock upon the conversion of the same, as reported in the Issuer's Current Report on Form 8-K, as filed with the Securities and Exchange Commission on September 17, 2025, and (ii) an additional 16,666,667 shares of Common Stock that the Reporting Person could acquire within 60 days upon the exercise of warrants.

---

**Item 1(a). Name of Issuer:**
PRECIGEN, INC.

**Item 1(b). Address of Issuer's Principal Executive Offices:**
85 10th Ave., 9th Floor, New York, NY 10011

**Item 2(a). Name of Person Filing:**
William H. Miller III Living Trust dated April 17, 2017

**Item 2(b). Address of Principal Business Office:**
1104 Kenilworth Drive, Suite 301
Towson, MD 21204

**Item 2(c). Citizenship:**
Florida

**Item 2(d). Title of Class of Securities:**
Common Stock

**Item 2(e). CUSIP Number:**
74017N105

**Item 3. If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:**

(a) [ ] Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).

(b) [ ] Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).

(c) [ ] Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).

(d) [ ] Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).

(e) [ ] An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);

(f) [ ] An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);

(g) [ ] A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);

(h) [ ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

(i) [ ] A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

(j) [ ] A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), if filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:

(k) [ ] Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).

**Item 4. Ownership:**

**(a) Amount beneficially owned:**

34,051,925 shares of Common Stock
See Row (9) of the cover page of the Reporting Person above and associated Note (A).

**(b) Percent of class:**

9.2%
See Row (11) of the cover page of the Reporting Person above and associated Note (B).

**(c) Number of shares as to which the person has:**

**(i) Sole power to vote or to direct the vote:**

34,051,925 shares
See Row (5) of the cover page of the Reporting Person above and associated Note (A).

**(ii) Shared power to vote or to direct the vote:**

0 shares

**(iii) Sole power to dispose or to direct the disposition of:**

34,051,925 shares
See Row (7) of the cover page of the Reporting Person above and associated Note (A).

**(iv) Shared power to dispose or to direct the disposition of:**

0 shares

**Item 5. Ownership of Five Percent or Less of a Class.**

[x] If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following.

**Item 6. Ownership of More than 5 Percent on Behalf of Another Person.**

Not Applicable

**Item 7. Identification and Classification of the Subsidiary**

Not Applicable

**Item 8. Identification and Classification of Members of the Group**

Not Applicable

**Item 9. Notice of Dissolution of Group**

Not Applicable

**Item 10. Certification:**

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**William H. Miller III Living Trust dated April 17, 2017**

**Date:** 09/23/2025

**By:** /s/ William H. Miller III

**Name & Title:** William H. Miller III, Trustee